BriaCell Therapeutics

BCTXNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$28.690 M

$3.29 +2.99%

Close of 6 Nov 2026

As of 6 Nov 2026, BriaCell Therapeutics (BCTX) has a market capitalization of $28.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.3M

Loss-making

Shares outstanding

8,732,381

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

BriaCell Therapeutics lists more than one class of stock. Company figures above cover all classes combined.

BCTXL BCTXZ

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#363Lite StrategyLITS$30.0M
#364Edesa BiotechEDSA$28.9M
#365BriaCell TherapeuticsBCTX$28.7M
#366Incannex HealthcareIXHL$28.6M
#367Annovis BioANVS$28.1M

What if BriaCell Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,233,582

Per share 984,198× higher

Bitcoin $1.53T

$174,963.51

Per share 53,253× higher

Apple $5.02T

$574,388.88

Per share 174,825× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for BriaCell Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.